| Bacillus anthracis |
Beta-lactamase II |
IC50 |
1060000.0 |
nM |
10.1016/j.bmcl.2012.08.012 |
| Bacteria |
Cell membrane |
Activity |
69.7 |
% |
10.1021/acsmedchemlett.2c00015 |
| Bacteria |
Cell membrane |
Activity |
76.4 |
% |
10.1021/acsmedchemlett.2c00015 |
| Candida parapsilosis |
Candida parapsilosis |
CFU/ml |
160.0 |
None |
10.1128/aac.00154-06 |
| Candida parapsilosis |
Candida parapsilosis |
CFU/ml |
500.0 |
None |
10.1128/aac.00154-06 |
| Candida parapsilosis |
Candida parapsilosis |
CFU/ml |
5000.0 |
None |
10.1128/aac.00154-06 |
| Cavia porcellus |
Ileum |
Activity |
49.7 |
% |
10.1021/np060073h |
| Crotalus adamanteus |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B |
IC50 |
74000.0 |
nM |
10.1007/s00044-011-9804-0 |
| Crotalus adamanteus |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B |
IC50 |
274000.0 |
nM |
10.1007/s00044-013-0523-6 |
| Enterobacter cloacae |
IMI-1 |
Activity |
nan |
None |
10.1128/aac.00491-07 |
| Enterococcus faecalis |
Enterococcus faecalis |
MBC |
2000.0 |
uM |
10.1021/acs.jmedchem.1c00168 |
| Enterococcus faecalis |
Enterococcus faecalis |
MBEC |
2000.0 |
uM |
10.1021/acs.jmedchem.1c00168 |
| Enterococcus faecalis |
Enterococcus faecalis |
MIC |
500000.0 |
nM |
10.1021/acs.jmedchem.1c00168 |
| Escherichia coli |
Beta-lactamase |
IZ |
21.66 |
mm |
10.1016/j.bmcl.2017.10.074 |
| Escherichia coli |
Escherichia coli |
MIC |
0.25 |
ug.mL-1 |
10.1016/j.bmc.2020.115902 |
| Escherichia coli |
Escherichia coli |
MIC |
nan |
None |
10.1016/j.bmc.2020.115902 |
| Escherichia coli |
Metallo-beta-lactamase NDM-4 |
IZ |
18.2 |
mm |
10.1016/j.ejmech.2019.01.083 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Amyloid-beta A4 protein |
IC50 |
7700.0 |
nM |
10.1021/jm400564j |
| Homo sapiens |
Amyloid-beta A4 protein |
IC50 |
28400.0 |
nM |
10.1021/jm400564j |
| Homo sapiens |
Amyloid-beta A4 protein |
Inhibition |
90.0 |
% |
10.1016/j.ejmech.2013.10.068 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Angiotensin-converting enzyme |
IC50 |
14000.0 |
nM |
10.1021/acs.jnatprod.7b00829 |
| Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
3548.1 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Eyes absent homolog 2 |
Activity |
nan |
None |
None |
| Homo sapiens |
Eyes absent homolog 2 |
IC50 |
65000.0 |
nM |
None |
| Homo sapiens |
Eyes absent homolog 2 |
IC50 |
100000.0 |
nM |
None |
| Homo sapiens |
Eyes absent homolog 2 |
IC50 |
380000.0 |
nM |
None |
| Homo sapiens |
Eyes absent homolog 2 |
IC50 |
1000000.0 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-8.06 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.06 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
281.8 |
nM |
None |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
3.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Human immunodeficiency virus type I enhancer-binding protein 1 |
Binding |
0.0 |
% |
10.1021/jm00051a002 |
| Homo sapiens |
Human immunodeficiency virus type I enhancer-binding protein 1 |
Binding |
16.0 |
% |
10.1021/jm00051a002 |
| Homo sapiens |
Human immunodeficiency virus type I enhancer-binding protein 1 |
Binding |
33.0 |
% |
10.1021/jm00051a002 |
| Homo sapiens |
Insulin-degrading enzyme |
Inhibition |
100.0 |
% |
10.1016/j.ejmech.2019.06.057 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Matrix metalloproteinase 13 |
Inhibition |
70.0 |
% |
10.1021/jm501284e |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
24336.5 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotransferrin |
Fe removed |
0.0 |
% |
10.1021/jm00357a022 |
| Homo sapiens |
Serotransferrin |
Fe removed |
37.0 |
% |
10.1021/jm00357a022 |
| Homo sapiens |
Serum amyloid P-component |
Inhibition |
100.0 |
% |
None |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
81.77 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
82.24 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
1258.9 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella pneumoniae |
Carbepenem-hydrolyzing beta-lactamase KPC |
Activity |
nan |
None |
10.1128/aac.00491-07 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Activity |
nan |
None |
10.1128/aac.00380-10 |
| Mus musculus |
Mus musculus |
ID/g |
0.01 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
0.21 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
1.53 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
1.54 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
1.64 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
1.81 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
2.41 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
2.73 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
3.21 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
3.49 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
4.21 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
5.45 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
7.45 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
7.56 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
7.77 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
8.09 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
9.12 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
9.21 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
10.3 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
39.8 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
53.9 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
56.5 |
% |
10.1021/jm990141f |
| Mus musculus |
Mus musculus |
ID/g |
85.94 |
% |
10.1021/jm990141f |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
Activity |
nan |
None |
10.1016/s0960-894x(01)00258-x |
| Pseudoalteromonas |
Pseudoalteromonas |
Activity |
nan |
None |
10.1128/aac.00449-07 |
| Pseudomonas aeruginosa |
Beta-lactamase |
IC50 |
27900.0 |
nM |
10.1016/j.bmcl.2012.08.012 |
| Pseudomonas aeruginosa |
Beta-lactamase VIM-1 |
IC50 |
9300.0 |
nM |
10.1128/aac.00465-08 |
| Pseudomonas aeruginosa |
Class B carbapenemase VIM-13 |
IC50 |
252600.0 |
nM |
10.1128/aac.00465-08 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Serratia fonticola |
Carbapenem-hydrolizing beta-lactamase SFC-1 |
Activity |
nan |
None |
10.1128/aac.00491-07 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
2.523 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
21.78 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-2.85 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.12 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.05 |
% |
10.6019/CHEMBL4495565 |
| Staphylococcus aureus |
Staphylococcus aureus |
CFU/ml |
480.0 |
None |
10.1128/aac.00154-06 |
| Staphylococcus aureus |
Staphylococcus aureus |
CFU/ml |
500.0 |
None |
10.1128/aac.00154-06 |
| Staphylococcus aureus |
Staphylococcus aureus |
CFU/ml |
5000.0 |
None |
10.1128/aac.00154-06 |
| Staphylococcus aureus |
Staphylococcus aureus |
MBC |
2000.0 |
uM |
10.1021/acs.jmedchem.1c00168 |
| Staphylococcus aureus |
Staphylococcus aureus |
MBC |
2000.0 |
uM |
10.1021/acs.jmedchem.5b02004 |
| Staphylococcus aureus |
Staphylococcus aureus |
MBC |
2000.0 |
uM |
10.1021/acs.jmedchem.7b01903 |
| Staphylococcus aureus |
Staphylococcus aureus |
MBEC |
2000.0 |
uM |
10.1021/acs.jmedchem.1c00168 |
| Staphylococcus aureus |
Staphylococcus aureus |
MBEC |
2000.0 |
uM |
10.1021/acs.jmedchem.5b02004 |
| Staphylococcus aureus |
Staphylococcus aureus |
MBEC |
2000.0 |
uM |
10.1021/acs.jmedchem.7b01903 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
25000.0 |
nM |
10.1021/acs.jmedchem.1c00168 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
25000.0 |
nM |
10.1021/acs.jmedchem.7b01903 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
125000.0 |
nM |
10.1021/acs.jmedchem.1c00168 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MBC |
1000.0 |
uM |
10.1021/acs.jmedchem.1c00168 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MBC |
1000.0 |
uM |
10.1021/acs.jmedchem.5b02004 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MBC |
1000.0 |
uM |
10.1021/acs.jmedchem.7b01903 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MBEC |
2000.0 |
uM |
10.1021/acs.jmedchem.1c00168 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MBEC |
2000.0 |
uM |
10.1021/acs.jmedchem.5b02004 |
| Staphylococcus epidermidis |
Staphylococcus epidermidis |
MBEC |
2000.0 |
uM |
10.1021/acs.jmedchem.7b01903 |
| None |
ADMET |
Activity |
3.0 |
% |
10.1021/acs.jmedchem.5b02004 |
| None |
ADMET |
log10(%HIA +10) |
1.176 |
None |
10.1016/j.ejmech.2010.11.005 |
| None |
Erythrocyte |
Activity |
1.0 |
% |
10.1021/acs.jmedchem.1c00168 |
| None |
Erythrocyte |
Activity |
3.0 |
% |
10.1021/acs.jmedchem.7b01903 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Activity |
43.67 |
% |
10.1007/s00044-013-0468-9 |
| None |
NON-PROTEIN TARGET |
EC50 |
3.4e-05 |
ug.mL-1 |
10.1007/s00044-012-9987-z |
| None |
NON-PROTEIN TARGET |
IC50 |
100.0 |
nM |
10.1016/j.bmc.2010.05.045 |
| None |
NON-PROTEIN TARGET |
IC50 |
54000.0 |
nM |
10.1021/jm400197m |
| None |
NON-PROTEIN TARGET |
IC50 |
185640.0 |
nM |
10.1016/j.bmc.2009.05.019 |
| None |
No relevant target |
Activity |
6.9 |
% |
10.1016/j.bmc.2016.09.006 |
| None |
No relevant target |
Activity |
80.0 |
% |
10.1016/j.bmc.2015.08.024 |
| None |
No relevant target |
Activity |
96.4 |
% |
10.1016/j.ejmech.2017.09.057 |
| None |
No relevant target |
Activity |
164.0 |
% |
10.1016/j.ejmech.2016.05.015 |
| None |
No relevant target |
Activity |
429.0 |
% |
10.1016/j.ejmech.2016.05.015 |
| None |
No relevant target |
Activity |
nan |
None |
10.1016/j.ejmech.2019.02.001 |
| None |
No relevant target |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113702 |
| None |
No relevant target |
Activity |
nan |
None |
10.1016/j.ejmech.2021.113779 |
| None |
No relevant target |
Activity |
nan |
None |
10.1021/acs.jmedchem.7b00407 |
| None |
No relevant target |
IC50 |
44.11 |
ug.mL-1 |
10.1016/j.ejmech.2018.07.007 |
| None |
No relevant target |
IC50 |
50.98 |
ug.mL-1 |
10.1016/j.bmc.2014.10.015 |
| None |
No relevant target |
IC50 |
1750.0 |
nM |
10.1016/j.ejmech.2021.113702 |
| None |
No relevant target |
IC50 |
12500.0 |
nM |
10.1016/j.ejmech.2021.113702 |
| None |
No relevant target |
IC50 |
20000.0 |
nM |
10.1016/j.ejmech.2016.04.012 |
| None |
No relevant target |
IC50 |
42000.0 |
nM |
10.1016/j.bmc.2016.09.006 |
| None |
No relevant target |
IC50 |
54000.0 |
nM |
10.1021/acs.jmedchem.5b00575 |
| None |
No relevant target |
IC50 |
200000.0 |
nM |
10.1016/j.ejmech.2021.113702 |
| None |
No relevant target |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.7b00741 |
| None |
No relevant target |
P |
0.13 |
M l-1 |
10.1016/s0960-894x(99)00527-2 |
| None |
Unchecked |
Activity |
10.0 |
% |
10.1021/acs.jmedchem.7b00407 |
| None |
Unchecked |
Activity |
309.0 |
% |
10.1021/jm0606342 |
| None |
Unchecked |
Activity |
343.0 |
% |
10.1021/jm0606342 |
| None |
Unchecked |
Activity |
475.0 |
% |
10.1021/jm0606342 |
| None |
Unchecked |
Activity |
482.0 |
% |
10.1021/jm0606342 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.7b00407 |
| None |
Unchecked |
EC50 |
10000.0 |
nM |
10.1016/s0960-894x(03)00280-4 |
| None |
Unchecked |
IC50 |
100.0 |
nM |
10.1021/np4000944 |
| None |
Unchecked |
IC50 |
540.0 |
nM |
10.1016/j.ejmech.2022.114174 |
| None |
Unchecked |
IC50 |
1600.0 |
nM |
10.1016/j.ejmech.2021.113667 |
| None |
Unchecked |
IC50 |
8470.0 |
nM |
10.1016/j.ejmech.2019.01.083 |
| None |
Unchecked |
IC50 |
102950.0 |
nM |
10.1016/j.bmc.2020.115873 |
| None |
Unchecked |
IC50 |
274000.0 |
nM |
10.1016/j.bmc.2011.12.041 |
| None |
Unchecked |
IC50 |
274000.0 |
nM |
10.1021/np040142x |
| None |
Unchecked |
IC50 |
277690.0 |
nM |
10.1016/j.bmc.2014.08.032 |
| None |
Unchecked |
IC50 |
80000000.0 |
nM |
10.1021/acs.jnatprod.9b00334 |
| None |
Unchecked |
Inhibition |
84.0 |
% |
10.1016/j.ejmech.2016.07.052 |
| None |
Unchecked |
Inhibition |
84.0 |
% |
10.1016/j.ejmech.2021.113975 |
| None |
Unchecked |
Inhibition |
87.0 |
% |
10.1016/j.ejmech.2021.113975 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.8b01310 |
| None |
Unchecked |
IZ |
13.9 |
mm |
10.1016/j.ejmech.2019.01.083 |
| None |
Unchecked |
Ki |
815000.0 |
nM |
10.1128/aac.00083-07 |
| None |
Unchecked |
Ki |
3500000.0 |
nM |
10.1021/jm00091a009 |
| None |
Unchecked |
MIC |
0.25 |
ug.mL-1 |
10.1016/j.bmc.2020.115902 |